Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Advanced Research Incubator in Biosciences (ARIB): A centre of excellence for disseminating quality biomedical research and boosting the next research generation for sustainable growth

Objective

Despite the influx of European regional development funds into the Czech Republic including the Central Bohemian Region (CBR), there is not yet a functional transfer environment in which innovation leads to products and services that drive the economic development of the region. This Teaming proposal will address the structural deficiency in the CBR by establishing “ARIB - Advanced Research Incubator in Biosciences”, a unique new institution designed to nurture the research and career development of young researchers who will generate the high quality innovative research findings and inventions needed to fill the newly established infrastructures with life. The source of excellence will be the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden, a flagship institute of the Max Planck Society and the excellence will be absorbed by the Institute of Molecular Genetics (IMG) in Prague, the flagship biomedical research institute of the Czech Academy of Sciences. MPI-CBG has a rich research landscape on which to draw examples, and the IMG can provide the best regional structural opportunities to exploit it. The first innovative high potential and synergistic research opportunities have been identified and are elaborated in the proposal. The proximity of Dresden and Prague is the most crucial factor to facilitate the effective transfer of excellence. The proposal seeks funding for preparation of a comprehensive business plan to implement a Teaming for Excellence strategy that will awaken the dormant research synergies between Dresden and Prague. A systematic inventory of the available assets, strengths and weaknesses will identify productive synergies between the two regions that when brought to fruition in ARIB, will serve as success stories for further implementation in the Czech Republic. Thus, ARIB will accelerate discoveries in biomedical research and transfer the results into the fertile environment of the nascent CBR technology cluster.

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSA - Coordination and support action

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-WIDESPREAD-2016-2017

See all projects funded under this call

Coordinator

USTAV MOLEKULARNI GENETIKY AV CR V.V.I.
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 230 048,75
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 230 048,75

Participants (1)

My booklet 0 0